title: [Pure red cell aplasia developed during treatment with erythropoietin. Complete remission during immunosuppressive therapy].
abstract: In a patient with chronic renal failure due to diabetes mellitus pure red-cell aplasia developed during treatment with erythropoietin (epoetin alfa). The treatment with erythropoietin was stopped and immunosuppressive therapy resulted in normalisation of the bone marrow function and increase of the Hb level to normal values. Pure red cell aplasia which develops during treatment with erythropoietin has recently been reported in a few other patients with anaemia due to chronic renal failure. Hitherto our patient is the first case reported in Denmark.
authors.affiliation: Medicinsk Afdeling F, Hillerød Sygehus, DK-3400 Hillerød. peboha@fa.dk
authors.forename: Thomas
authors.initials: T
authors.lastname: Høi-Hansen
authors.forename: Anne M Falensteen
authors.initials: AM
authors.lastname: Lauritzen
authors.forename: Per Boye
authors.initials: PB
authors.lastname: Hansen
mesh_terms: D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000009:adverse effects*; D006397:Hematinics / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced*; D012075:Remission, Spontaneous
chemical_list: D006397:Hematinics; D007166:Immunosuppressive Agents; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa